CATALYST PHARMACEUTICALS INC shareholders Q3 2023

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 159,791$1,8685.34%
Opaleye Management Inc. 1,205,000$14,086,4504.58%
GABLES CAPITAL MANAGEMENT INC. 431,955$5,049,5543.51%
JW Asset Management, LLC 563,392$6,586,0522.85%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,192,000$95,764,4802.11%
Seaport Global Advisors, LLC 45,941$537,0501.61%
Capital Impact Advisors, LLC 67,067$784,0131.31%
Ikarian Capital, LLC 505,862$5,913,5270.71%
MOODY ALDRICH PARTNERS LLC 273,512$3,197,3550.61%
Paradiem, LLC 166,905$1,951,1190.59%
Yorktown Management & Research Co Inc 40,500$473,4450.53%
CLARK ESTATES INC/NY 188,000$2,197,7200.40%
AFFINITY INVESTMENT ADVISORS, LLC 48,740$569,7710.37%
OBERWEIS ASSET MANAGEMENT INC/ 293,600$3,432,1840.36%
Westover Capital Advisors, LLC 85,518$999,7050.36%
HUSSMAN STRATEGIC ADVISORS, INC. 157,500$1,841,1750.35%
Jackson Creek Investment Advisors LLC 68,210$7970.34%
GLOBEFLEX CAPITAL L P 234,284$2,738,7800.32%
NAVELLIER & ASSOCIATES INC 136,614$1,597,0180.27%
EMC Capital Management 28,483$3330.24%
External links

This page lists CATALYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view CATALYST PHARMACEUTICALS INC's shareholder history, click here.